Skip to content

Evaluation the effect of Cichorium intybus L. on change the liver enzymes in burn patients

Evaluation the effect of Cichorium intybus L. on change the liver enzymes in burn patients: a randomized double- blind placebo-controlled clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180609040016N1
Enrollment
60
Registered
2018-06-18
Start date
2018-07-23
Completion date
Unknown
Last updated
2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver disorder. Fatty (change of) liver, not elsewhere classified

Interventions

Intervention 1: Intervention group: : Cichorium intybus L is bought from market of medicinal plants. Once verified by the botanist, it is used to prepare herbal extracts.so the Cichorium intybus L is

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: The burn time for patients is less than two days Their burn are is between 10% - 50% body surface percentage

Exclusion criteria

Exclusion criteria: The patients are not intubated No history for liver disease, hyperlipidemia, seizure No pregnancy

Design outcomes

Primary

MeasureTime frame
ALT level. Timepoint: Every 3 days until discharg. Method of measurement: Biochemistry analysis.;AST level. Timepoint: Every 3 days until discharg. Method of measurement: Biochemistry analysis.;?Albumin level. Timepoint: Every 3 days until discharg. Method of measurement: Biochemistry analysis.;CRP level. Timepoint: Every 3 days until discharg. Method of measurement: Biochemistry analysis.;Creatinin level. Timepoint: Every 3 days until discharg. Method of measurement: Biochemistry analysis.;Urea level. Timepoint: Every 3 days until discharg. Method of measurement: Biochemistry analysis.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbdlokhalegh Keshavarzi

Shiraz University of Medical Sciences

keshavarzi@sums.ac.ir+98 71 3230 5410

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026